Hepatocellular carcinoma: signaling pathways and therapeutic advances

Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma